{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"Orphan Therapeutics Accelerator licenses stalled pediatric gene therapy","author_name":"techandbusiness.org · Tech & Business","thumbnail_url":"https://s.yimg.com/lo/mysterio/api/17efdd0647c2d2fcf32a8f6ba05688368e8e8b25bdba00e652a095f8d058baec/lightyear_networkapi/resizefill_w1200%3Bquality_80%3Bformat_webp/https%3A%2F%2Fmedia.zenfs.com%2Fen%2Fprnewswire.com%2Fec4529b99813081ef99ab594b45782e0.png","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Tech & Business</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/lG7lVjmLlWNWZ6HV4gPJrv\" style=\"color:#fff;text-decoration:none;\">Orphan Therapeutics Accelerator licenses stalled pediatric gene therapy</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Orphan Therapeutics Accelerator said it has agreed to license an investigational gene therapy for ornithine transcarbamylase deficiency from UCL Ventures and Children's Medical Research Institute. The...</p>\n    </blockquote>"}